Cargando…

Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients

BACKGROUND: This study evaluated the treatment results of lymph node (LN) oligo-recurrence in esophageal cancer patients treated with salvage radiotherapy (RT) in a multi-institutional retrospective study. METHODS: Eligibility criteria for this retrospective analysis were: the primary lesion of esop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Hideomi, Jingu, Keiichi, Niibe, Yuzuru, Katsui, Kuniaki, Matsumoto, Toshihiko, Nishina, Tomohiro, Terahara, Atsuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319190/ https://www.ncbi.nlm.nih.gov/pubmed/28219406 http://dx.doi.org/10.1186/s13014-017-0780-5

Ejemplares similares

Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
por: Jingu, Keiichi, et al.
Publicado: (2017)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases
por: Takahashi, Wataru, et al.
Publicado: (2012)

Oligometastases/Oligo-Recurrence of Lung Cancer
por: Niibe, Yuzuru, et al.
Publicado: (2013)

Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy
por: Niibe, Yuzuru, et al.
Publicado: (2010)

Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature
por: Niibe, Yuzuru, et al.
Publicado: (2012)

Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects
por: Niibe, Yuzuru, et al.
Publicado: (2016)

Long-Term Survival After Repeated Salvage Chemoradiation Therapy for Metastatic Lymph Node Recurrence in Advanced Gastric Cancer: A Case Report
por: Katano, Atsuto, et al.
Publicado: (2023)

Oligometastases: history and future vision of breast cancer
por: Niibe, Yuzuru, et al.
Publicado: (2020)

Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report
por: Okuma, Kae, et al.
Publicado: (2011)

Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy
por: Kobayashi, Reiko, et al.
Publicado: (2016)

Prognostic factors in patients after definitive chemoradiation using involved‐field radiotherapy for esophageal cancer in a phase II study
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Repeated episodes of spontaneous regression/progression of cervical adenocarcinoma after adjuvant chemoradiation therapy: a case report
por: Katano, Atsuto, et al.
Publicado: (2015)

Details of recurrence sites after definitive radiation therapy for cervical cancer
por: Kobayashi, Reiko, et al.
Publicado: (2016)

A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer
por: Patel, Pretesh R., et al.
Publicado: (2012)

Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy
por: Yamashita, Hideomi, et al.
Publicado: (2010)

Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review
por: Aoki, Shuri, et al.
Publicado: (2020)

Factors related to primary cancer death and non‐primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer
por: Tabata, Ken-ichi, et al.
Publicado: (2012)

Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients
por: Aoki, Shuri, et al.
Publicado: (2020)

Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study
por: Yamashita, Hideomi, et al.
Publicado: (2017)

Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status
por: Zhang, Jinmeng, et al.
Publicado: (2022)

Long-term clinical outcomes of salvage pelvic radiation therapy for oligo-recurrent pelvic lymph nodes after definitive external-beam radiation therapy for non-metastatic prostate cancer
por: Sato, Genki Edward, et al.
Publicado: (2020)

Carbon ion radiotherapy for oligo-recurrent lung metastases from colorectal cancer: a feasibility study
por: Takahashi, Wataru, et al.
Publicado: (2014)

Proton beam therapy followed by pembrolizumab for giant ocular surface conjunctival malignant melanoma: A case report
por: Matsuo, Toshihiko, et al.
Publicado: (2022)

Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013)

Salvage radiotherapy for second oligo-recurrence in patients with breast cancer
por: Miyata, Mari, et al.
Publicado: (2018)

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome
por: Adenis, Antoine, et al.
Publicado: (2013)

Trimodality Therapy vs Definitive Chemoradiation in Older Adults With Locally Advanced Esophageal Cancer
por: Gaber, Charles E, et al.
Publicado: (2022)

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation
por: Lischalk, Jonathan W., et al.
Publicado: (2021)

Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
por: Schreiner, Waldemar, et al.
Publicado: (2016)

Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis
por: Yamashita, Hideomi, et al.
Publicado: (2017)

Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer()
por: Warren, Samantha, et al.
Publicado: (2014)

Factors Predictive of Protracted Course of Radiation Therapy in Patients Treated with Definitive Chemoradiation for Cervical Cancer
por: Zaki, Mark, et al.
Publicado: (2016)

Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy
por: Kagawa, Tomo, et al.
Publicado: (2018)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)

Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors
por: Cha, Yu Jin, et al.
Publicado: (2017)

Therapie des oligo- und polytopmetastasierten Prostatakarzinoms
por: Hadaschik, B. A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5fa02ids68e8ftfc690siufhmd